AzTrials
AzTrials

Brain Injuries, TraumaticNCT02589509

Cognitive Rehabilitation and Brain Activity of Attention Control in TBI

A study testing Direct-attention training using web-based BrainHQ and Goal Management Training (GMT) in people with Brain Injuries, Traumatic, run by VA Office of Research and Development at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The purpose of this study is to test an innovative combination of direct-attention training and metacognitive training in the treatment of attention impairments in Veterans with moderate-to-severe traumatic brain injury (TBI) who report experiencing attentional problems. Read more about this study

Who is it for?
Ages 21 to 55 years
Conditions the study is for
Brain Injuries, Traumatic
What is being tested?
Direct-attention training using web-based BrainHQ and Goal Management Training (GMT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
1 Dec 2015to 31 Oct 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • OEF/OIF/OND Veterans with moderate or severe TBI as described by DOD/VA common definition.
  • Self-report of attentional problems, confirmed with psychometric testing.
  • Ruff 2 \& 7 selective attention task score <= 1.5 standard deviations from demographically-matched norms.
  • Able to participate in study at 12-60 months post injury without contraindications.
  • Age 21-55 years.
  • Willingness to be randomized and to participate in treatment procedures.
Show all 11Show fewer
  • Capacity to visit the laboratory for repeated treatment and testing sessions.
  • Access to internet-enabled home computer.
  • English as Native language.
  • Adequate reading comprehension to allow completion of study-related questionnaires.
  • Reliable digit span (RDS) score > 7.

Who cannot join

  • Pre-existing neurological disorder associated with cerebral dysfunction (e.g., stroke, history of epilepsy or chronic seizure disorder).
  • Current alcohol or drug use/dependence.
  • Pre-existing severe psychiatric disorder (e.g., schizophrenia, bipolar disorder) or history of psychiatric diagnosis sufficiently severe to have resulted in inpatient hospitalization.
  • Current suicidal or homicidal ideation.
  • Reported involvement in current litigation.
  • Reported history of pre-injury learning disability.
Show all 10Show fewer
  • Not competent to provide written informed consent (i.e., not able to demonstrate understanding or expectations of study and potential risks of participation).
  • Does not fully understand the nature of the study and requirements of participation.
  • Does not understand task instructions.
  • Validity testing score on RDS <= 7.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • North Florida/South Georgia Veterans Health System, Gainesville, FL

    Gainesville, Florida, 32608

Other trials in United States

About this study

Official title: Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI

The purpose of this study is to test an innovative combination of direct-attention training and metacognitive training in the treatment of attention impairments in Veterans with moderate-to-severe traumatic brain injury (TBI) who report experiencing attentional problems. Enrolled participants will be randomized to receive either the direct-attention training or metacognitive training first and then will be crossed over to receive the opposite intervention. The study will consist of two treatment periods of 4 weeks and a post-treatment 4 weeks later. In addition to the rehabilitation treatments, participants will also perform measures of complex functional activities (e.g., independent activities of daily living or IADLs) and neurocognitive tests of attention-control functions. Participants will also perform an attentional task that probes the function of three different attentional systems while brain wave activity (i.e., electroencephalography or EEG) is being recorded in order to assess changes in brain function that may be improved by the rehabilitation approach. Planned enrollment will be 36 Veterans.

Read the detailed description

Attention impairment is ubiquitous in TBI survivors. This is a devastating impairment because attention is the backbone of cognitive systems. Attention is requisite for other cognitive processes that are vital to everyday functioning such as memory, problem solving, language skills, and the cognitive control of behavior. Studies of attention training have shown improved attention on laboratory measures, but limited translation to real-world tasks. Notably, these previously-tested rehabilitation approaches have not included training in the very cognitive processes needed for translation of training to everyday tasks which include internal verbalization and self-monitoring, also called metacognitive strategies. One training method for metacognitive strategies has shown promise, but is lacking in basic attention training. Rehabilitation specialists have recently argued for a rehabilitation approach wherein both basic foundational attention and metacognitive strategies should be synergistically combined. Consequently, the investigators will test an innovative combination of direct-attention training and metacognitive training for which the other compensates disadvantages of each. Because of the promise of each type of training separately, and the potential additive effects of the combination, it is critical to test this combined attention and metacognitive training in Veteran survivors of chronic moderate-to-severe traumatic brain injury (TBI). The investigators will address the following two specific aims: the investigators propose to conduct a pilot study to examine cognitive rehabilitation therapy (CRT) effects in a group of Veterans with chronic moderate to severe TBI (m/sTBI), focused on remediating attention-control impairments using both direct-attention and metacognitive-strategy training approaches in a AB/BA crossover design with 1-month follow-up to address the following two specific aims: 1) Test treatment response to combined direct-attention and metacognitive-strategy training in Veterans with chronic m/sTBI; and 2) identify mechanisms and biomarkers of rehabilitation-related neuroplasticity. Under the first aim the investigators will test for effects of combined direct-attention and metacognitive-strategy training on measures of complex functional activities and neurocognitive tests of attention-control functions. Under the second aim, the investigators will test effects of the their CRT approach on behavioral and brain activity while participants perform a well-validated attentional task that probes the function of three dissociable attentional systems. The approach is innovative because it combines a theoretically motivated and novel approach to address a significant source of disability in Veteran survivors of TBI. The proposed research is significant because findings will form the foundation for a larger-scale trial to enable us to determine the durability of gains and the functional impact of treatment on Veteran's real world activities and to more positively shape healthcare for our Veterans who are suffering from TBI. Outcome measures will include standardized tests of neurocognitive functioning such as attention and other cognitive skills, measures of self care, ability to live independently, social role participation, life satisfaction, TBI-related quality of life, mood/anxiety, and attention-related scalp-recorded brain event-related potentials (ERPs, derived from electroencephalography).

Being tested
Direct-attention training using web-based BrainHQ, Goal Management Training (GMT)
Keywords
Event-related potentials, Attention, Cognitive rehabilitation, Independent activities of daily living
Medical subject headings
Brain Injuries, Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Direct-attention training using web-based BrainHQBehavioural

    BrainHQ (by Posit Science Corp.) computerized attention training using the following modules: "Divided attention," "Target tracker," "Double Decision," "Mixed Signals," and "Freeze Frame."

  • Goal Management Training (GMT)Behavioural

    A compensatory metacognitive strategy-based intervention program that teaches strategies for improving attentional control and problem solving.

Study groups in NCT02589509
Study groupRoleWhat they receive
Direct-MetacognitiveExperimentalDirect attention training followed by metacognitive strategy training
Receives: Behavioral: Direct-attention training using web-based BrainHQ; Behavioral: Goal Management Training (GMT)
Metacognitive-DirectExperimentalMetacognitive strategy training followed by direct-attention training
Receives: Behavioral: Direct-attention training using web-based BrainHQ; Behavioral: Goal Management Training (GMT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Timed Instrumental Activities of Daily Living (TIADL)

    The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions. The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.

    Measured: Baseline TIADL Reaction Time assessed pretreatment

  2. Timed Instrumental Activities of Daily Living (TIADL)

    The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions. The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.

    Measured: Change from Baseline in TIADL Reaction Time assessed at 8 weeks

  3. Timed Instrumental Activities of Daily Living (TIADL)

    The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions. The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.

    Measured: Change from Baseline in TIADL Reaction Time assessed at 12 weeks (1-month post treatment)

  4. Timed Instrumental Activities of Daily Living (TIADL) - Accuracy

    The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions. The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.

    Measured: Change from Baseline in TIADL Accuracy assessed at 4 weeks

  5. Timed Instrumental Activities of Daily Living (TIADL) - Accuracy

    The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions. The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.

    Measured: Change from Baseline in TIADL Accuracy assessed at 8 weeks

  6. Timed Instrumental Activities of Daily Living (TIADL) - Accuracy

    The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions. The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.

    Measured: Change from Baseline in TIADL Accuracy assessed at 12 weeks (1 month post treatment)

  7. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Ability Score

    Assesses global outcome, including ability, adjustment and community participation indices.

    Measured: Change from Baseline in MPAI-4 Ability Score assessed at 4 weeks

  8. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Ability Score

    Assesses global outcome, including ability, adjustment and community participation indices.

    Measured: Change from Baseline in MPAI-4 Ability Score assessed at 8 weeks

  9. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Ability Score

    Assesses global outcome, including ability, adjustment and community participation indices.

    Measured: Change from Baseline in MPAI-4 Ability Score assessed at 12 weeks (1 month post treatment)

  10. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Adjustment Score

    Assesses global outcome, including ability, adjustment and community participation indices.

    Measured: Change from Baseline in MPAI-4 Adjustment Score assessed at 4 weeks

  11. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Adjustment Score

    Assesses global outcome, including ability, adjustment and community participation indices.

    Measured: Change from Baseline in MPAI-4 Adjustment Score assessed at 8 weeks

  12. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Adjustment Score

    Assesses global outcome, including ability, adjustment and community participation indices.

    Measured: Change from Baseline in MPAI-4 Adjustment Score assessed at 12 weeks (1 month post treatment)

  13. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Participation Score

    Assesses global outcome, including ability, adjustment and community participation indices.

    Measured: Change from Baseline in MPAI-4 Participation Score assessed at 4 weeks

  14. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Participation Score

    Assesses global outcome, including ability, adjustment and community participation indices.

    Measured: Change from Baseline in MPAI-4 Participation Score assessed at 8 weeks

  15. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Participation Score

    Assesses global outcome, including ability, adjustment and community participation indices.

    Measured: Change from Baseline in MPAI-4 Participation Score assessed at 12 weeks (1 month post treatment)

  16. Timed Instrumental Activities of Daily Living (TIADL) - Reaction Time score

    The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions. The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.

    Measured: Baseline (pretreatment) on TIADL - Reaction Time score

  17. Timed Instrumental Activities of Daily Living (TIADL) - Accuracy score

    The TIADL is a timed, performance-based measure of everyday cognition/instrumental activities of daily living (IADLs) in which participants are presented with common everyday stimuli (e.g., medication labels, transportation schedules, cake-mix ingredients, phone book) and asked to answer questions. The dependent variables are the number of accurate responses and response speed to each accurate item is recorded.

    Measured: Baseline (pretreatment) on TIADL - Accuracy score

  18. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4)

    Assesses global outcome, including ability, adjustment and community participation indices. The MPAI-4 is a 35-item questionnaire-based inventory that will be completed study staff and TBI survivors. It offers three subscales (Ability, Adjustment, and Participation) and has well-documented psychometric properties. MPAI-4 items represent the range of physical, cognitive, emotional, behavioral, and societal problems that TBI survivors often encounter; it also assess major obstacles to community integration.

    Measured: Baseline (pretreatment) MPAI-4 Adjustment score

  19. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4)

    Assesses global outcome, including ability, adjustment and community participation indices. The MPAI-4 is a 35-item questionnaire-based inventory that will be completed study staff and TBI survivors. It offers three subscales (Ability, Adjustment, and Participation) and has well-documented psychometric properties. MPAI-4 items represent the range of physical, cognitive, emotional, behavioral, and societal problems that TBI survivors often encounter; it also assess major obstacles to community integration.

    Measured: Baseline (pretreatment) MPAI-4 Participation score

  20. Attention Network Test (ANT) Alerting Reaction Time score

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in Altering Reaction Time Score assessed at 4 weeks

  21. Attention Network Test (ANT) Alerting Reaction Time score

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in Altering Reaction Time Score assessed at 8 weeks

  22. Attention Network Test (ANT) Alerting Reaction Time score

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in Altering Reaction Time Score assessed at 12 weeks (1 month post treatment)

  23. Attention Network Test (ANT) Orient Reaction Time score

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Baseline (pretreatment) Orienting Reaction Time score

  24. Attention Network Test (ANT) Orienting Reaction Time score

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in Orienting Reaction Time Score assessed at 4 weeks

  25. Attention Network Test (ANT) Orienting Reaction Time score

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in Orienting Reaction Time Score assessed at 8 weeks

  26. Attention Network Test (ANT) Orienting Reaction Time score

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in Orienting Reaction Time Score assessed at 12 weeks (1 month post treatment)

  27. Attention Network Test (ANT) Executive-Control Reaction Time score

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Baseline (pretreatment) Executive-Control Reaction Time score

  28. Attention Network Test (ANT) Executive-Control Reaction Time score

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in Executive-Control Reaction Time Score assessed at 4 weeks

  29. Attention Network Test (ANT) Executive-Control Reaction Time score

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in Executive-Control Reaction Time Score assessed at 8 weeks

  30. Attention Network Test (ANT) Executive-Control Reaction Time score

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in Executive-Control Reaction Time Score assessed at 12 weeks (1 month post treatment)

  31. Attention Network Test (ANT) Alerting Reaction Time score

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Baseline (pretreatment) Alerting Reaction Time score

  32. ANT ERP (N1) Alerting Amplitude

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Baseline ANT ERP (N1) Alerting Amplitude assessed pretreatment

  33. ANT ERP (N1) Alerting Amplitude

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in ANT ERP (N1) Alerting Amplitude assessed at 4 weeks

  34. ANT ERP (N1) Alerting Amplitude

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in ANT ERP (N1) Alerting Amplitude assessed at 8 weeks

  35. ANT ERP (N1) Alerting Amplitude

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in ANT ERP (N1) Alerting Amplitude assessed at 12 weeks (1 month post treatment)

  36. ANT ERP (N1) Orienting Amplitude

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Baseline ANT ERP (N1) Orienting Amplitude assessed pretreatment

  37. ANT ERP (N1) Orienting Amplitude

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in ANT ERP (N1) Orienting Amplitude assessed at 4 weeks

  38. ANT ERP (N1) Orienting Amplitude

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in ANT ERP (N1) Orienting Amplitude assessed at 8 weeks

  39. ANT ERP (N1) Orienting Amplitude

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Change from Baseline in ANT ERP (N1) Orienting Amplitude assessed at 12 weeks (1 month post treatment)

  40. ANT ERP (P3) Executive Amplitude

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Baseline ANT ERP (P3) Executive Amplitude assessed pretreatment

  41. ANT ERP (P3) Executive Amplitude

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Baseline ANT ERP (P3) Executive Amplitude assessed at 4 weeks

  42. ANT ERP (P3) Executive Amplitude

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Baseline ANT ERP (P3) Executive Amplitude assessed at 8 weeks

  43. ANT ERP (P3) Executive Amplitude

    The ANT combines a covert cueing paradigm with a classic flanker task to behaviorally probe independent but interactive components of attention in a single experimental paradigm. Scalp-recorded electroencephalography (EEG) will be acquired from 64 sensors while participants perform the ANT to derive event-related potentials (ERPs) reflecting alerting, orienting, and executive-control components of attention and enable probing of brain plasticity associated with attention rehabilitation.

    Measured: Baseline ANT ERP (P3) Executive Amplitude assessed at 12 weeks (1 month post treatment)

  44. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Ability Score

    Assesses global outcome, including ability, adjustment and community participation indices. The MPAI-4 is a 35-item questionnaire-based inventory that will be completed study staff and TBI survivors. It offers three subscales (Ability, Adjustment, and Participation) and has well-documented psychometric properties. MPAI-4 items represent the range of physical, cognitive, emotional, behavioral, and societal problems that TBI survivors often encounter; it also assess major obstacles to community integration.

    Measured: Baseline MPAI-4 Ability Score assessed pretreatment

  45. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Adjustment Score

    Assesses global outcome, including ability, adjustment and community participation indices. The MPAI-4 is a 35-item questionnaire-based inventory that will be completed study staff and TBI survivors. It offers three subscales (Ability, Adjustment, and Participation) and has well-documented psychometric properties. MPAI-4 items represent the range of physical, cognitive, emotional, behavioral, and societal problems that TBI survivors often encounter; it also assess major obstacles to community integration.

    Measured: Baseline MPAI-4 Adjustment Score assessed pretreatment

  46. Mayo-Portland Adaptability Inventory, 4th edition (MPAI-4) - Participation Score

    Assesses global outcome, including ability, adjustment and community participation indices. The MPAI-4 is a 35-item questionnaire-based inventory that will be completed study staff and TBI survivors. It offers three subscales (Ability, Adjustment, and Participation) and has well-documented psychometric properties. MPAI-4 items represent the range of physical, cognitive, emotional, behavioral, and societal problems that TBI survivors often encounter; it also assess major obstacles to community integration.

    Measured: Baseline MPAI-4 Participation Score assessed pretreatment

Secondary outcomes (8)
  1. Mindful Attention Awareness Scale-Lapses Only (MAAS-LO)

    The MAAS-LO is a 12-item 6-point Likert-type scale designed to measure everyday attentional lapses (infrequent to very frequent).

    Measured: Change from Baseline in MAAS-LO Score assessed at 4 weeks

  2. Mindful Attention Awareness Scale-Lapses Only (MAAS-LO)

    The MAAS-LO is a 12-item 6-point Likert-type scale designed to measure everyday attentional lapses (infrequent to very frequent).

    Measured: Change from Baseline in MAAS-LO Score assessed at 8 weeks

  3. Mindful Attention Awareness Scale-Lapses Only (MAAS-LO)

    The MAAS-LO is a 12-item 6-point Likert-type scale designed to measure everyday attentional lapses (infrequent to very frequent).

    Measured: Change from Baseline in MAAS-LO Score assessed at 12 weeks (1 month post treatment)

  4. Satisfaction with Life Scale (SWLS)

    The SWLS assesses patient's perceived satisfaction with life. It is a 5-item 7-point Likert-type scale with a range from "strongly disagree" to "strongly agree." The total score is used as a measure of satisfaction with life.

    Measured: Baseline SWLS Score assessed pretreatment

  5. Mindful Attention Awareness Scale-Lapses Only (MAAS-LO)

    The MAAS-LO is a 12-item 6-point Likert-type scale designed to measure everyday attentional lapses (infrequent to very frequent).

    Measured: Baseline (pretreatment) on MAAS-LO

  6. Satisfaction with Life Scale (SWLS)

    The SWLS assesses patient's perceived satisfaction with life. It is a 5-item 7-point Likert-type scale with a range from "strongly disagree" to "strongly agree." The total score is used as a measure of satisfaction with life.

    Measured: Change from Baseline in SWLS Score assessed at 4 weeks

  7. Satisfaction with Life Scale (SWLS)

    The SWLS assesses patient's perceived satisfaction with life. It is a 5-item 7-point Likert-type scale with a range from "strongly disagree" to "strongly agree." The total score is used as a measure of satisfaction with life.

    Measured: Change from Baseline in SWLS Score assessed at 8 weeks

  8. Satisfaction with Life Scale (SWLS)

    The SWLS assesses patient's perceived satisfaction with life. It is a 5-item 7-point Likert-type scale with a range from "strongly disagree" to "strongly agree." The total score is used as a measure of satisfaction with life.

    Measured: Change from Baseline in SWLS Score assessed at 12 weeks (1 month post treatment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2015 (estimated)
  2. Study start1 Dec 2015
  3. Primary completion31 Oct 2018
  4. Study completion31 Oct 2018

Why it stopped: No one was recruited

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02589509
Sponsor's protocol ID
N1920-P
Other IDs
I21RX001920-01A1
Status last verified
Feb 2022
First submitted
13 Oct 2015
Last updated
15 Feb 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Direct-attention training using web-based BrainHQ and Goal Management Training (GMT) in people with Brain Injuries, Traumatic, run by VA Office of Research and Development at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 15 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Timed Instrumental Activities of Daily Living (TIADL) (time frame: Baseline TIADL Reaction Time assessed pretreatment). The study lists 46 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in